Company Filing History:
6 out of 932 
1 out of 1 
1 out of 213 
Years Active: 2015-2025
Title: Yu Tian Wang: Innovator in Peptide Research
Introduction
Yu Tian Wang is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of peptide research, holding a total of 8 patents. His work focuses on innovative methods for protein knockdown, which have potential applications in treating various diseases.
Latest Patents
One of Yu Tian Wang's latest patents is centered around peptide-directed protein knockdown. This invention provides a peptide that includes a chaperone-mediated autophagy (CMA)-targeting signal domain, a protein-binding domain that selectively binds to a target cytosolic protein, and a cell membrane penetrating domain (CMPD). The invention outlines methods for reducing the intracellular expression level of an endogenous target protein both in vitro and in animal models. Furthermore, it offers methods for treating pathological conditions in animals, particularly neurodegenerative diseases. In one embodiment, the target cytosolic protein is death-associated protein kinase 1, and the CMPD is the protein transduction domain of the HIV-1 Tat protein.
Career Highlights
Yu Tian Wang has worked with notable institutions, including the University of British Columbia and Qingdao Primedicine Pharmaceutical Company, Ltd. His research has significantly advanced the understanding of peptide applications in medical science.
Collaborations
Yu Tian Wang has collaborated with esteemed colleagues such as Xuelai Fan and Jack Wuyang Jin. Their combined expertise has contributed to the success of various research projects.
Conclusion
Yu Tian Wang is a distinguished inventor whose work in peptide research has the potential to revolutionize treatments for neurodegenerative diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.